-
the BBB to the site of action. We will also explore more delivery systems aiming to bypass the BBB with targeted drug delivery. The successful applicant will gain diverse training in molecular cell biology
-
, Clinical Genetics/Genomics, Cellular Pathology, Healthcare Management, Quality Management. Pharmacology and/or Physiology Biochemistry and/or Molecular biology Bioinformatics and Biostatistics You will have
-
the implementation of Molecular Koch’s postulates has yet to be derived. Thus, to date, it has not proven possible to generate mutants of either C. scindens or C. hiranonis in which the gene(s) encoding the pivotal
-
molecular heterogeneity, the architecture of the tumour microenvironment and the identification of biomarkers associated with therapeutic success and failure. The JvGCRC is prioritising initiatives in
-
Bachelor’s Honour’s Degree (or UK equivalent according to NARIC) in Cell Biology, Biochemistry, Molecular Biology, or a related Biosciences related subject. Fees and funding This PhD is self-funded.
-
to NARIC) with a minimum of a commendation, and/or a UK 1st Class / 2.1 Bachelor’s Honour’s Degree (or UK equivalent according to NARIC) in Cell Biology, Biochemistry, Molecular Biology, or a related
-
of a range of molecular cell biology techniques, including mammalian cell culture, 3D cultures, expression analysis, immunofluorescence, real time QPCR and Western blot analysis. The Ahmed lab
-
, Biochemistry, Molecular Biology, or a related Biosciences related subject. Fees and funding This opportunity is for self-funded PhD students. Applicants are encouraged to apply for external funding and we will
-
according to NARIC) in Cell Biology, Biochemistry, Molecular Biology, or a related Biosciences subject. Fees and funding This opportunity is for self-funded PhD students. Applicants are encouraged to apply
-
the successful candidate to work alongside established academics and accomplished partners from Wugen with the aim to characterise the molecular and functional features of a “memory” NK-cell immunotherapy product